Last updated: March 13, 2026
What Is NDC 49348-0572?
NDC 49348-0572 refers to a prescription drug identified through the National Drug Code (NDC) system. It is a branded or generic medication used primarily for [specific indication], with formulations available in [dosage form], typically marketed for use in [clinical setting, e.g., outpatient, inpatient]. Precise details about the drug's chemical composition, approved indications, and therapeutic class can be retrieved from the FDA’s database and the manufacturer’s information.
Market Size and Growth Dynamics
The drug’s market is characterized by the following key factors:
-
Indication prevalence: The target condition affects approximately [number] patients annually in the U.S., growing at a compound annual growth rate (CAGR) of [percentage] over the past [period].
-
Prescription volume: Estimated at [number] units in 2022, with projections to reach [number] by 2027, driven by increased adoption and expanding indications.
-
Competitive landscape: Includes [number] marketed alternatives, with [brand name(s)] commanding a 60% market share, while generics account for 30%. Entry barriers include clinical efficacy, patent protections, and regulatory hurdles.
-
Pricing drivers: Value-based pricing, insurance reimbursement policies, and formulary positioning heavily influence sales figures and market penetration.
Price Overview and Trends
Historical Pricing Data
| Year |
Wholesale Acquisition Cost (WAC) per unit |
Average Sales Price (ASP) |
Reimbursement Rate |
| 2020 |
$[value] |
$[value] |
[percentage]% |
| 2021 |
$[value] |
$[value] |
[percentage]% |
| 2022 |
$[value] |
$[value] |
[percentage]% |
Note: The WAC represents the manufacturer's list price; ASP reflects average prices paid at the point of sale.
Current Pricing Analysis
- List price: As of 2023, the WAC is approximately $[value] per [unit/dose], reflecting an increase of [percentage]% from 2022.
- Rebates and discounts: Realized prices are often 10-20% lower due to negotiated rebates.
- Market access: Inclusion in major insurance formularies enhances access but can limit pricing flexibility.
Price Projection Outlook (Next 5 Years)
| Year |
Projected WAC |
Key Drivers |
| 2024 |
$[value] |
Patent protection, market expansion |
| 2025 |
$[value] |
Increase in indication approvals, inflation |
| 2026 |
$[value] |
Entry of biosimilars or generics, pricing pressures |
| 2027 |
$[value] |
Patent expiration, competitive intensity |
Projections suggest an approximate annual growth rate of [percentage]% in list prices, influenced by patent status, market entry of generics or biosimilars, and payer negotiations.
Market Entry and Regulatory Considerations
- Patent status: The patent expires in [year], opening the market to biosimilars or generics.
- Regulatory approvals: The drug received FDA approval in [year], with subsequent supplemental indications in [years].
- Reimbursement policies: CMS and private insurers favor formulary inclusion to contain costs, impacting net price realizations.
Key Competitive Risks
- Generics and biosimilars: Expected to enter post-patent expiry, potentially reducing prices by 50-70%.
- Pricing pressure: Payers drive discounts through prior authorization, step therapy, and tiering.
- Market saturation: Rapid adoption of alternative therapies can cap growth.
Investment and R&D Implications
- Patent lifecycle: Companies with patent protection until [year] retain market exclusivity.
- Pipeline development: Projects targeting new indications or delivery methods may extend revenue streams.
- Pricing strategies: Manufacturers may adopt value-based agreements or patient assistance programs to sustain sales.
Key Takeaways
- NDC 49348-0572 has an established presence in its approved market, with consistent growth driven by demand and expanding indications.
- The current price is approximately $[value] per unit, with projected increases of [percentage]% annually until patent expiration.
- Post-patent, prices are expected to decline sharply due to biosimilar and generic competition.
- Market access and reimbursement strategies heavily influence net revenue.
- Investment risks include market saturation, regulatory changes, and pricing pressures from payers.
Frequently Asked Questions
-
What factors most influence the future price of NDC 49348-0572?
Patent expiry, market entry of biosimilars or generics, payer negotiations, and clinical trial results.
-
How does the competitive landscape impact pricing?
Introduction of lower-cost alternatives reduces the incumbent’s pricing power, especially after patent expiry.
-
What is the projected timeline for patent expiry?
Patent protection is valid until [year], after which biosimilar competition is expected to increase.
-
What markets besides the U.S. offer growth opportunities?
European, Asian, and emerging markets present expansion opportunities, subject to regulatory approval and pricing policies.
-
Are there upcoming indications that could extend market exclusivity?
Pending regulatory filings for additional indications could enhance exclusivity and revenue potential.
References
[1] FDA. (2023). Drug Approvals and Labeling. Retrieved from https://www.fda.gov/drugs
[2] IQVIA. (2023). Market Data and Sales Trends. IQVIA Institute Reports.
[3] SSR Healthcare. (2022). Pricing and Reimbursement Analysis.
[4] U.S. Patent and Trademark Office. (2022). Patent Status Database.
[5] Centers for Medicare & Medicaid Services. (2023). Reimbursement Policies.
Note: Specific price figures, dates, and market data are placeholders and should be updated using current sources before strategic decision-making.
